- Plaça Sant Joan, 16, 08520 Corró d'Avall, Barcelona, Spain
- +34 696 34 27 84
Dr. Nigel T. Fleming is CEO and Co-Founder at ADVentura Capital SL, Executive Chairman at A-CUBE, Inc., Chairman & Chief Executive Officer at Minerva Healthcare, Inc., Chairman & Chief Executive Officer at G2B Pharma, Inc., and Independent Director at Impax Laboratories, Inc. He is on the Board of Directors at Impax Laboratories, Inc. and Genmedica Therapeutics SL.
Dr. Fleming was previously employed as Chief Executive Officer by BioVision, Inc., Chief Executive Officer by Genica Pharmaceuticals Corp., Chairman, CEO & VP-Business Development by Athena Diagnostics, Inc., and Lecturer by Harvard University. He also served on the board at Examplar, The Institute for OneWorld Health, Athena Neurosciences, Inc., and Elan Pharmaceuticals, Inc.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from the University of Cambridge.